Fenoprofen Calcium Capsule
Product Images NDC 85437-502

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fenoprofen Calcium (NDC 85437-502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Coral Way Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chart1 (Chart1)

Chart1 (Chart1)
A data table presenting clinically significant drug interactions with Fenoprofen. It details drugs that interfere with hemostasis, such as anticoagulants, aspirin, and ACE inhibitors, with sections on clinical impact and recommended interventions for patients using these medications concurrently with Fenoprofen.*
FDA Label Image

Chart2 (Chart2)

Chart2 (Chart2)
Text panel from a drug label describing clinical impact and intervention guidance for concomitant use of fenoprofen calcium with various drugs including ACE-inhibitors, ARBs, beta-blockers, diuretics, digoxin, lithium, methotrexate, and cyclosporine. It includes warnings about monitoring renal function, blood pressure, and drug toxicity during combined therapy.*
FDA Label Image

Chart3 (Chart3)

Chart3 (Chart3)
This image shows a text panel discussing drug interaction information related to Fenoprofen Calcium. It covers clinical impacts, interventions, and monitoring recommendations for concomitant use with cyclosporine, other NSAIDs or salicylates, pemetrexed, phenobarbital, and hydantoins, sulfonamides, or sulfonylureas, highlighting potential risks such as renal function worsening, myelosuppression, GI toxicity, and altered plasma half-life.*
FDA Label Image

Formula (Figure 01)

Formula (Figure 01)
Chemical structure of Fenoprofen Calcium, showing the molecular arrangement with the calcium salt dihydrate form, including aromatic rings and carboxylate groups as depicted in the diagram.*
FDA Label Image

Label-fc (Label Fc)

Label-fc (Label Fc)
Fenoprofen Calcium 300 mg oral capsules label, USP, manufactured for Coral Way Pharma, LLC. The label includes the NDC 85437-502-10 and indicates a package count of 100 capsules. Instructions highlight dispensing a Medication Guide to each patient and storage at controlled room temperature (20°-25°C). Caution for FD&C Yellow No. 5 (Tartrazine) as a color additive is noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.